Carotenoids inhibit DNA synthesis in human aortic smooth muscle cells

K L Carpenter1, S J Hardwick, V Albarani

  • 1University of Cambridge, Department of Pathology, UK. klhc@mole.bio.cam.ac.uk

FEBS Letters
|April 28, 1999
PubMed

Insights

Dietary carotenoids like lycopene can inhibit smooth muscle cell proliferation. This suggests potential in vivo benefits for these compounds in preventing cell growth.

Area of Science:

  • Cell Biology
  • Nutritional Science
  • Biochemistry

Background:

  • Human aortic smooth muscle cells (HASMCs) play a role in vascular health.
  • Cell proliferation is a key process in various physiological and pathological conditions.
  • Carotenoids are natural pigments with potential health benefits.

Purpose of the Study:

  • To investigate the antiproliferative effects of various dietary carotenoids on HASMCs.
  • To determine the potency of different carotenoids in inhibiting DNA synthesis.

Main Methods:

  • Quiescent HASMCs were restimulated with foetal calf serum.
  • Cells were treated with beta-carotene, canthaxanthin, zeaxanthin, lycopene, lutein, or beta-cryptoxanthin.
  • DNA synthesis was measured using [methyl-3H]thymidine incorporation.

Main Results:

  • Most tested carotenoids, including beta-carotene, zeaxanthin, lycopene, and beta-cryptoxanthin, demonstrated concentration-dependent inhibition of DNA synthesis.
  • Lycopene exhibited the most potent antiproliferative effect among the tested carotenoids.
  • Canthaxanthin and lutein showed no significant effect on DNA synthesis.

Conclusions:

  • Dietary carotenoids possess antiproliferative properties against HASMCs.
  • Lycopene is a particularly effective carotenoid in inhibiting smooth muscle cell DNA synthesis.
  • These findings suggest that dietary carotenoids may have significant in vivo relevance for controlling cell proliferation.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...